FSC 250/50mcg

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Asthma

Phase 4

GSK BHR Study (Sont)

CompletedNCT00920543

GlaxoSmithKlineAsthma

Start: 2003-02-28End: 2004-10-31Updated: 2016-09-01

GSK BHR Study (Sont - Second Study)

CompletedNCT01324362

GlaxoSmithKlineAsthma

Start: 2003-01-31End: 2004-10-31Updated: 2016-09-01